In8Bio (INAB) Depreciation & Amortization (CF) (2020 - 2026)
In8Bio (INAB) reported Depreciation & Amortization (CF) of $300,000 for Q2 2026, unchanged from $300,000 a year earlier and up 22.4% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, In8Bio's Depreciation & Amortization (CF) came in at $945,000, down 19.6% year-over-year; for FY2025, it was $1 million, unchanged from FY2024.
- Depreciation & Amortization (CF) has a five-year compound annual growth rate of 58.5% (FY2020 to FY2025).
- By year, Depreciation & Amortization (CF) came in at $1 million in FY2024 (unchanged), $1 million in FY2023 (+116.9%), $461,000 in FY2022 (-14.2%) and $537,000 in FY2021 (+437.0%).
- Year over year, Depreciation & Amortization (CF) gained in two of the last eight quarters, with an average decline of 0.4%.
- The high point for year-over-year Depreciation & Amortization (CF) in five years was Q3 2021 (growth of 540.9%); the low point was Q3 2022 (a decline of 36.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $245,000 (Q1 2026), $200,000 (Q4 2025) and $200,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 1.62 Bn |
| 10 | In8Bio | 20.25 Mn | -58.10 Mn | - | 300,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 245,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 239,000.00 |
| Dec 31, 2023 | 275,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 243,000.00 |
| Dec 31, 2022 | 47,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | 22,000.00 |
API Access
In8Bio Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();